CoChat

CDC25B Mediates Rapamycin-Induced Oncogenic Responses in Cancer Cells

Open access
Chen, Run-qiang, Yang, Qing-kai, Lu, Bing-wen, Yi, Wei, Cantin, Greg, Chen, Yan-ling, Fearns, Colleen, Yates, John R., Lee, Jiing-Dwan · 2009 · Cancer Research
Cited by 118

The DOI matches its Crossref record.

Abstract

Because the mammalian target of rapamycin (mTOR) pathway is commonly deregulated in human cancer, mTOR inhibitors, rapamycin and its derivatives, are being actively tested in cancer clinical trials. Clinical updates indicate that the anticancer effect of these drugs is limited, perhaps due to rapamycin-dependent induction of oncogenic cascades by an as yet unclear mechanism. As such, we investigated rapamycin-dependent phosphoproteomics and discovered that 250 phosphosites in 161 cellular proteins were sensitive to rapamycin. Among these, rapamycin regulated four kinases and four phosphatases. A siRNA-dependent screen of these proteins showed that AKT induction by rapamycin was attenuated by depleting cellular CDC25B phosphatase. Rapamycin induces the phosphorylation of CDC25B at Serine375, and mutating this site to Alanine substantially reduced CDC25B phosphatase activity. Additionally, expression of CDC25B (S375A) inhibited the AKT activation by rapamycin, indicating that phosphorylation of CDC25B is critical for CDC25B activity and its ability to transduce rapamycin-induced oncogenic AKT activity. Importantly, we also found that CDC25B depletion in various cancer cell lines enhanced the anticancer effect of rapamycin. Together, using rapamycin phosphoproteomics, we not only advance the global mechanistic understanding of the action of rapamycin but also show that CDC25B may serve as a drug target for improving mTOR-targeted cancer therapies. [Cancer Res 2009;69(6):OF2663–8]

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-08-3222

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 118

Metadata

Authors
Chen, R.-Q., Yang, Q.-K., Lu, B.-W., Yi, W., Cantin, G., Chen, Y.-L., Fearns, C., Yates, J. R., & Lee, J.-D.
Venue
Cancer Research
Published
2009-03-15
Volume
69
Issue
6
Pages
2663-2668
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2166567576
Cited by
118
References
0
FWCI
3.96
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CDC25B Mediates Rapamycin-Induced Oncogenic Responses in Cancer Cells. https://app.cochat.ai/papers/10.1158/0008-5472.can-08-3222
The paper
Chen, R.-Q., Yang, Q.-K., Lu, B.-W., Yi, W., Cantin, G., Chen, Y.-L., Fearns, C., Yates, J. R., & Lee, J.-D. (2009). CDC25B Mediates Rapamycin-Induced Oncogenic Responses in Cancer Cells. Cancer Research. https://doi.org/10.1158/0008-5472.can-08-3222

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.